Abstract | OBJECTIVE: METHODS: 32 CIA models were established. 16 CIA rats were transplanted with MSCs, and others were used as nontreatment CIA controls. The concentrations of IL-22 and RANKL in serum were detected by ELISA and those in synovial tissue of rats' joints by immunohistochemical staining. In addition, the expression of RANKL mRNA was measured by RT-PCR in the fibroblast-like synoviocytes (FLSs), cultured with IL-22 in vitro, which were delivered from the joints of CIA rats treated with or without MSCs. RESULTS: The transplantation of MSCs into CIA rats relieved the destruction of joints, measured by AI score, X-ray, and histopathology. MSCs also reduced the expression of IL-22 and RANKL in serum by ELISA (P < 0.001) and similarly in FLSs by immunohistochemical staining. In vitro, IL-22 induced significantly the expression of RANKL mRNA in cultured FLSs in a dose-dependent manner, whereas this induction was significantly reduced in FLSs derived from CIA rats transplanted with MSCs (normal controls: F = 79.33, P < 0.001; CIA controls: F = 712.72, P < 0.001; and CIA-MSC rats: F = 139.04, P < 0.001). CONCLUSION: Our results suggest that the transplantation of MSCs can reduce the expression of RANKL in vivo by downregulating the levels of IL-22, thereby ameliorating the degree of RA bone destruction. This study provides a theoretical basis for a potential therapy of RA with MSCs, and IL-22 and RANKL may become two new targets to treat RA.
|
Authors | Fang Li, Xin Li, Guiyan Liu, Chong Gao, Xiaofeng Li |
Journal | Journal of immunology research
(J Immunol Res)
Vol. 2019
Pg. 8459281
( 2019)
ISSN: 2314-7156 [Electronic] Egypt |
PMID | 31828174
(Publication Type: Journal Article)
|
Copyright | Copyright © 2019 Fang Li et al. |
Chemical References |
- Interleukins
- RANK Ligand
- interleukin-22
|
Topics |
- Animals
- Arthritis, Experimental
(genetics, immunology, pathology, therapy)
- Female
- Fibroblasts
(drug effects, immunology, pathology)
- Gene Expression Regulation
- Interleukins
(antagonists & inhibitors, genetics, immunology, pharmacology)
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells
(cytology, immunology)
- Primary Cell Culture
- RANK Ligand
(antagonists & inhibitors, genetics, immunology)
- Rats
- Rats, Sprague-Dawley
- Signal Transduction
- Synovial Membrane
(immunology, pathology)
- Synoviocytes
(drug effects, immunology, pathology)
|